NEU vs TRI

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

NEU

NEUREN FPO NZ [NEU]

43LOW

TRI

TRIVARX FPO [TRI]

42LOW

Score Breakdown

NEU TRI
Technical
69
57
Catalyst
50
50
Sentiment
50
50
Fundamental
52
45
Momentum
22
67
Risk Gate
36
35

Key Metrics

NEU Metric TRI
$1.5BMarket Cap$19.6M
683KAvg Volume (20d)1.2M
+5.9%Short Interest+0.0%
$22.98552-Week High$0.035
$8.61052-Week Low$0.007
+0.1%Daily Change+13.3%
$11.945Entry Price$0.017
+8.7%ROE-12.1%
+47.1%Profit MarginN/A

Active Signals

NEU Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Revenue in sharp decline (-81%)
●Piotroski F-Score strong (7/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

TRI Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic just turned bullish from a low level — early reversal sign
●Trading below both moving averages — the trend is working against this one
●Lagging the Small Ords index — relative strength of 0.76, underperforming its peers
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Strong cash runway (13 quarters)
●4C filed 2026-01-29
●Revenue in sharp decline (-100%)

Ask Scout AI to compare NEU and TRI in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
NEU Full Analysis → TRI Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).